|1.||Cefali, E: 1 article (09/2007)|
|2.||Tolbert, D: 1 article (09/2007)|
|3.||Menon, R: 1 article (09/2007)|
|4.||Bays, Harold E: 1 article (07/2004)|
|5.||Gupta, Eric K: 1 article (03/2002)|
|6.||Ito, Matthew K: 1 article (03/2002)|
03/01/2002 - "Only two slowly absorbed niacin products have been approved by the FDA for the treatment of dyslipidemia; they are Niaspan (Kos Pharmaceuticals, Inc., Miami, FL) and Advicor (Kos Pharmaceuticals, Inc., Miami, FL). "
09/01/2007 - "Lovastatin and extended-release (ER) niacin in a fixed dose combination (Advicor) is approved for the treatment of dyslipidemia. "
07/01/2004 - "This review summarizes the efficacy and safety of extended-release niacin/lovastatin (Advicor, Kos Pharmaceuticals Inc.), the first combination product approved for the management of dyslipidemia."
|1.||Niacin (Nicotinic Acid)